The volunteers 'bodies responded by producing 3 to 5 times as much as normal of a hormone called plasminogen activator inhibitor-1. ❋ Unknown (2010)
Urokinase also activates a substance in blood vessels called plasminogen and turns it into plasmin, another protein-destroying enzyme. ❋ Unknown (2010)
The experimental pre-clinical treatment involved putting a naturally occurring substance called plasminogen activator inhibitor-1 (PAI-1) into the brains of newborn rats, said Chia-Yi Kuan, M.D. ❋ Unknown (2009)
Robinson and her colleagues measured several blood components involved in clotting, including fats and clotting factors such as plasminogen-activator inhibitor-1 (PAI-1) for the following eight hours. ❋ Unknown (2009)
However, researchers said that people who suffer wake-up strokes may not be treated with tissue plasminogen activator tPA when they arrive at hospital because it's often unclear exactly when the stroke occurred. ❋ Ann Lukits (2011)
As tissue plasminogen activator is manufactured using recombinant biotechnology techniques, it is referred to as rtPA as well as tPA in the study. ❋ Ann Lukits (2011)
Blood flow can be restored if tissue plasminogen activator, or tPA, is administered soon after the stroke occurs. ❋ Ann Lukits (2011)
Mackey says "wake-up" stroke sufferers are more likely to miss out on a potentially life-saving clot-busting medication called tissue plasminogen activator, or tPA, that can only be given within the first few hours after stroke symptoms begin. ❋ Unknown (2011)
Kidwell says many people aren't aware there is a treatment for stroke, called tPA, or tissue plasminogen activator. ❋ Unknown (2011)
If given within three hours of the start of symptoms, a clot-busting drug called tissue plasminogen activator tPA may reduce long-term disability for the most common type of stroke. tPA is the only FDA-approved medication for the treatment of stroke within three hours of stroke symptom onset. ❋ Dr. Nalini Chilkov (2011)
If given within three hours of the start of symptoms, a clot-busting drug called tissue plasminogen activator tPA may reduce long-term disability for the most common type of stroke. tPA is the only FDA-approved medication for the treatment of stroke within three hours of stroke symptom onset.â¨â¨ ❋ Dr. Nalini Chilkov (2011)
In the most common type of stroke, in which a clot blocks blood flow to the brain, studies show that quick administration of the drug tPA, or tissue plasminogen activator, can improve outcomes. ❋ Unknown (2009)
So when, in 1987, researchers slipped a human gene into mice so that they produced a human protein in their milk, "molecular pharmers" saw their chance: Researchers at Tufts and the Genzyme Corp. of Cambridge, Mass., engineered goats to produce tissue plasminogen activator (t-PA), a protein that dissolves blood clots and extends the lives of cardiac patients. ❋ Unknown (2008)
An ambulance rushed Kelly to the local hospital, where doctors made a quick diagnosis and began an intravenous drip of tissue plasminogen activator (tPA). ❋ Unknown (2008)
Clot-Buster Wins Support A study indicated that the clot-busting stroke drug TPA, for tissue plasminogen activator, should be used in more patients than regulators have so far approved. ❋ Unknown (2008)